WHO ICTRP trial
A Randomised, Double-Blind, Placebo-Controlled, Two-Sequence, Two-Period…
NL-OMON34656 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON34656 |
|---|---|
| Public title | A Randomised, Double-Blind, Placebo-Controlled, Two-Sequence, Two-Period, Crossover Study to Evaluate the Effect of SMP-028 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects |
| Scientific title | A Randomised, Double-Blind, Placebo-Controlled, Two-Sequence, Two-Period, Crossover Study to Evaluate the Effect of SMP-028 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects - OC interaction study with SMP-028 |
| Primary sponsor | Dainippon Sumitomo Pharma Europe Ltd. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | asthma chronic inflammation of the lungs;10006436;asthma;chronic inflammation of the lungs |
| Interventions | The study will start with a screening. A physical examination and different standard test (ECG, blood pressure) will be performed during the screening appointment. Also a cervical smear and an vaginal ultrasound will be performed. Blood and… |
| Registration date | Jan 15, 2010 |
| Target size | 30 |
| Secondary IDs | 2009-012710-43;NL31064.056.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: